To the full analysis
Fluidra stock: growth
FDR.MCFluidra reported $2.46B in revenue for fiscal 2025, up 4% on the prior year, up 8% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
7.8%
per year from 2006 to 2025, per share 4.6%
Earnings (Annual rate)
10.1%
per year from 2006 to 2025, per share 6.9%
Free cash flow (Annual rate)
13.1%
per year from 2006 to 2025, per share 9.7%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 8.0% | 12.9% | 7.8% |
| Revenue per share | 8.5% | 7.1% | 4.6% |
| Earnings | 12.8% | 29.8% | 10.1% |
| Earnings per share | 13.2% | 22.7% | 6.9% |
| Free cash flow | 3.8% | 27.5% | 13.1% |
| Free cash flow per share | 4.2% | 21.0% | 9.7% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $592.12M | $31.54M | $32.41M |
| 2007 | $752.25M | $38.48M | $11.58M |
| 2008 | $745.25M | $25.28M | $13.52M |
| 2009 | $629.41M | −$6.39M | $72.21M |
| 2010 | $660.14M | $19.71M | $43.08M |
| 2011 | $703.71M | $16.71M | $20M |
| 2012 | $709.94M | $16.07M | $11.89M |
| 2013 | $669.48M | −$11.34M | $13.82M |
| 2014 | $670.55M | $7.36M | $30.56M |
| 2015 | $733.32M | $14.4M | $29.47M |
| 2016 | $790.35M | $26.67M | $44.05M |
| 2017 | $883.55M | $34.41M | $45.36M |
| 2018 | $1.16B | −$37.59M | −$8.16M |
| 2019 | $1.54B | $9.22M | $120.23M |
| 2020 | $1.67B | $106.81M | $277.85M |
| 2021 | $2.46B | $279.64M | $300.47M |
| 2022 | $2.69B | $177.22M | $46.44M |
| 2023 | $2.31B | $126.13M | $404.23M |
| 2024 | $2.37B | $152.99M | $263.17M |
| 2025 | $2.46B | $195.05M | $334.73M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = €0.9024)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Jul 2020)
- Valuation signal Undervalued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.